Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 322

1.

Macitentan improves risk categorization for liver transplant mortality in patients with portopulmonary hypertension: A PORTICO study post-hoc analysis.

Krowka M, Cottreel E, Hoeper MM, Kim NH, Martin N, Sitbon O, Bosch J.

Liver Transpl. 2020 Mar 9. doi: 10.1002/lt.25747. [Epub ahead of print]

PMID:
32150762
2.

Effect of therapeutic plasma exchange on endothelial activation and coagulation-related parameters in septic shock.

Stahl K, Schmidt JJ, Seeliger B, Schmidt BMW, Welte T, Haller H, Hoeper MM, Budde U, Bode C, David S.

Crit Care. 2020 Mar 2;24(1):71. doi: 10.1186/s13054-020-2799-5.

3.

Metacognitive Therapy for Adjustment Disorder in a Patient With Newly Diagnosed Pulmonary Arterial Hypertension: A Case Report.

Winter L, Naumann F, Olsson K, Fuge J, Hoeper MM, Kahl KG.

Front Psychol. 2020 Feb 12;11:143. doi: 10.3389/fpsyg.2020.00143. eCollection 2020.

4.

Extracorporeal cytokine removal in severe CAR-T cell associated cytokine release syndrome.

Stahl K, Schmidt BMW, Hoeper MM, Skripuletz T, Möhn N, Beutel G, Eder M, Welte T, Ganser A, Falk CS, Koenecke C, David S.

J Crit Care. 2020 Feb 19;57:124-129. doi: 10.1016/j.jcrc.2020.02.010. [Epub ahead of print]

PMID:
32113143
5.

Chronic Thromboembolic Pulmonary Hypertension Perioperative Monitoring Using Phase-Resolved Functional Lung (PREFUL)-MRI.

Pöhler GH, Klimes F, Voskrebenzev A, Behrendt L, Czerner C, Gutberlet M, Cebotari S, Ius F, Fegbeutel C, Schoenfeld C, Kaireit TF, Hauck EF, Olsson KM, Hoeper MM, Wacker F, Vogel-Claussen J.

J Magn Reson Imaging. 2020 Feb 24. doi: 10.1002/jmri.27097. [Epub ahead of print]

PMID:
32096280
6.

Systemic Consequences of Pulmonary Hypertension and Right-Sided Heart Failure.

Rosenkranz S, Howard LS, Gomberg-Maitland M, Hoeper MM.

Circulation. 2020 Feb 25;141(8):678-693. doi: 10.1161/CIRCULATIONAHA.116.022362. Epub 2020 Feb 24.

PMID:
32091921
7.

Risk assessment in pulmonary arterial hypertension: Insights from the GRIPHON study.

Sitbon O, Chin KM, Channick RN, Benza RL, Di Scala L, Gaine S, Ghofrani HA, Lang IM, McLaughlin VV, Preiss R, Rubin LJ, Simonneau G, Tapson VF, Galiè N, Hoeper MM.

J Heart Lung Transplant. 2020 Apr;39(4):300-309. doi: 10.1016/j.healun.2019.12.013. Epub 2020 Jan 21.

8.

Current and future treatments of pulmonary arterial hypertension.

Sommer N, Ghofrani HA, Pak O, Bonnet S, Provencher S, Sitbon O, Rosenkranz S, Hoeper MM, Kiely DG.

Br J Pharmacol. 2020 Feb 7. doi: 10.1111/bph.15016. [Epub ahead of print] Review.

PMID:
32034759
9.

Exercise Pulmonary Hypertension Is Back.

Hoeper MM.

J Am Coll Cardiol. 2020 Jan 7;75(1):27-28. doi: 10.1016/j.jacc.2019.11.010. No abstract available.

PMID:
31918831
10.

"Better be awake"-a role for awake extracorporeal membrane oxygenation in acute respiratory distress syndrome due to Pneumocystis pneumonia.

Stahl K, Seeliger B, Hoeper MM, David S.

Crit Care. 2019 Dec 23;23(1):418. doi: 10.1186/s13054-019-2703-3. No abstract available.

11.

The revised definition of pulmonary hypertension: exploring the impact on patient management.

Simonneau G, Hoeper MM.

Eur Heart J Suppl. 2019 Dec;21(Suppl K):K4-K8. doi: 10.1093/eurheartj/suz211. Epub 2019 Dec 17.

12.

Extracorporeal Membrane Oxygenation for Severe ARDS Due to Immune Diffuse Alveolar Hemorrhage: A Retrospective Observational Study.

Seeliger B, Stahl K, Schenk H, Schmidt JJ, Wiesner O, Welte T, Kuehn C, Bauersachs J, Hoeper MM, David S.

Chest. 2020 Mar;157(3):744-747. doi: 10.1016/j.chest.2019.10.021. Epub 2019 Nov 9. No abstract available.

PMID:
31711988
13.

Maintenance Immunosuppression Is Associated With Better Outcome in the 2017/2018 Influenza Epidemic.

Stahl K, Seeliger B, Busch M, Wiesner O, Welte T, Eder M, Schäfer A, Bauersachs J, Haller H, Heim A, Hoeper MM, David S.

Open Forum Infect Dis. 2019 Sep 24;6(10):ofz381. doi: 10.1093/ofid/ofz381. eCollection 2019 Oct.

14.

Patients with pulmonary arterial hypertension with and without cardiovascular risk factors: Results from the AMBITION trial.

McLaughlin VV, Vachiery JL, Oudiz RJ, Rosenkranz S, Galiè N, Barberà JA, Frost AE, Ghofrani HA, Peacock AJ, Simonneau G, Rubin LJ, Blair C, Langley J, Hoeper MM; AMBITION Study Group.

J Heart Lung Transplant. 2019 Dec;38(12):1286-1295. doi: 10.1016/j.healun.2019.09.010. Epub 2019 Sep 17.

15.

Nonocclusive Mesenteric Ischemia and Interventional Local Vasodilatory Therapy: A Meta-Analysis and Systematic Review of the Literature.

Stahl K, Rittgerodt N, Busch M, Maschke SK, Schneider A, Manns MP, Fuge J, Meyer BC, Hoeper MM, Hinrichs JB, David S.

J Intensive Care Med. 2020 Feb;35(2):128-139. doi: 10.1177/0885066619879884. Epub 2019 Oct 23.

PMID:
31645176
16.

Clinical outcomes stratified by baseline functional class after initial combination therapy for pulmonary arterial hypertension.

White RJ, Vonk-Noordegraaf A, Rosenkranz S, Oudiz RJ, McLaughlin VV, Hoeper MM, Grünig E, Ghofrani HA, Chakinala MM, Barberà JA, Blair C, Langley J, Frost AE.

Respir Res. 2019 Sep 12;20(1):208. doi: 10.1186/s12931-019-1180-1.

17.

Riociguat for idiopathic interstitial pneumonia-associated pulmonary hypertension (RISE-IIP): a randomised, placebo-controlled phase 2b study.

Nathan SD, Behr J, Collard HR, Cottin V, Hoeper MM, Martinez FJ, Corte TJ, Keogh AM, Leuchte H, Mogulkoc N, Ulrich S, Wuyts WA, Yao Z, Boateng F, Wells AU.

Lancet Respir Med. 2019 Sep;7(9):780-790. doi: 10.1016/S2213-2600(19)30250-4. Epub 2019 Aug 12.

PMID:
31416769
18.

Therapeutic plasma exchange in acute liver failure.

Stahl K, Hadem J, Schneider A, Manns MP, Wiesner O, Schmidt BMW, Hoeper MM, Busch M, David S.

J Clin Apher. 2019 Oct;34(5):589-597. doi: 10.1002/jca.21737. Epub 2019 Jul 26.

PMID:
31348553
19.

Pulmonary hypertension in HFpEF and HFrEF: Pathophysiology, diagnosis, treatment approaches.

Rosenkranz S, Kramer T, Gerhardt F, Opitz C, Olsson KM, Hoeper MM.

Herz. 2019 Sep;44(6):483-490. doi: 10.1007/s00059-019-4831-6.

PMID:
31317203
20.

[Hemodynamic Definition of Pulmonary Hypertension: Commentary on the Proposed Change by the 6th World Symposium on Pulmonary Hypertension].

Rosenkranz S, Diller GP, Dumitrescu D, Ewert R, Ghofrani HA, Grünig E, Halank M, Held M, Kaemmerer H, Klose H, Kovacs G, Konstantinides S, Lang IM, Lange TJ, Leuchte H, Mayer E, Olschewski A, Olschewski H, Olsson KM, Opitz C, Schermuly RT, Seeger W, Wilkens H, Hoeper MM.

Dtsch Med Wochenschr. 2019 Sep;144(19):1367-1372. doi: 10.1055/a-0918-3772. Epub 2019 Jul 5. German.

21.

Macitentan for the treatment of portopulmonary hypertension (PORTICO): a multicentre, randomised, double-blind, placebo-controlled, phase 4 trial.

Sitbon O, Bosch J, Cottreel E, Csonka D, de Groote P, Hoeper MM, Kim NH, Martin N, Savale L, Krowka M.

Lancet Respir Med. 2019 Jul;7(7):594-604. doi: 10.1016/S2213-2600(19)30091-8. Epub 2019 Jun 6.

PMID:
31178422
22.

Extracorporeal membrane oxygenation for acute respiratory distress syndrome due to Pneumocystis pneumonia.

Stahl K, Schenk H, Seeliger B, Wiesner O, Schmidt JJ, Bauersachs J, Welte T, Kühn C, Haverich A, Hoeper MM, David S.

Eur Respir J. 2019 Sep 19;54(3). pii: 1900410. doi: 10.1183/13993003.00410-2019. Print 2019 Sep. No abstract available.

PMID:
31151957
23.

Intravenous treprostinil as an add-on therapy in patients with pulmonary arterial hypertension.

Olsson KM, Richter MJ, Kamp JC, Gall H, Heine A, Ghofrani HA, Fuge J, Ewert R, Hoeper MM.

J Heart Lung Transplant. 2019 Jul;38(7):748-756. doi: 10.1016/j.healun.2019.05.002. Epub 2019 May 7.

24.

Early discharge and home treatment of patients with low-risk pulmonary embolism with the oral factor Xa inhibitor rivaroxaban: an international multicentre single-arm clinical trial.

Barco S, Schmidtmann I, Ageno W, Bauersachs RM, Becattini C, Bernardi E, Beyer-Westendorf J, Bonacchini L, Brachmann J, Christ M, Czihal M, Duerschmied D, Empen K, Espinola-Klein C, Ficker JH, Fonseca C, Genth-Zotz S, Jiménez D, Harjola VP, Held M, Iogna Prat L, Lange TJ, Manolis A, Meyer A, Mustonen P, Rauch-Kroehnert U, Ruiz-Artacho P, Schellong S, Schwaiblmair M, Stahrenberg R, Westerweel PE, Wild PS, Konstantinides SV, Lankeit M; HoT-PE Investigators .

Eur Heart J. 2020 Jan 21;41(4):509-518. doi: 10.1093/eurheartj/ehz367.

PMID:
31120118
25.

Association of N-Terminal Pro Brain Natriuretic Peptide and Long-Term Outcome in Patients With Pulmonary Arterial Hypertension.

Chin KM, Rubin LJ, Channick R, Di Scala L, Gaine S, Galiè N, Ghofrani HA, Hoeper MM, Lang IM, McLaughlin VV, Preiss R, Simonneau G, Sitbon O, Tapson VF.

Circulation. 2019 May 21;139(21):2440-2450. doi: 10.1161/CIRCULATIONAHA.118.039360.

26.

Risk assessment in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension.

Humbert M, Farber HW, Ghofrani HA, Benza RL, Busse D, Meier C, Hoeper MM.

Eur Respir J. 2019 Jun 5;53(6). pii: 1802004. doi: 10.1183/13993003.02004-2018. Print 2019 Jun.

27.

The new haemodynamic definition of pulmonary hypertension: evidence prevails, finally!

Hoeper MM, Humbert M.

Eur Respir J. 2019 Mar 28;53(3). pii: 1900038. doi: 10.1183/13993003.00038-2019. Print 2019 Mar. No abstract available.

PMID:
30923177
28.

A Retrospective Analysis of Nonocclusive Mesenteric Ischemia in Medical and Surgical ICU Patients: Clinical Data on Demography, Clinical Signs, and Survival.

Stahl K, Busch M, Maschke SK, Schneider A, Manns MP, Fuge J, Wiesner O, Meyer BC, Hoeper MM, Hinrichs JB, David S.

J Intensive Care Med. 2019 Mar 25:885066619837911. doi: 10.1177/0885066619837911. [Epub ahead of print]

PMID:
30909787
29.

Evaluation of a newly developed 2D parametric parenchymal blood flow technique with an automated vessel suppression algorithm in patients with chronic thromboembolic pulmonary hypertension undergoing balloon pulmonary angioplasty.

Maschke SK, Winther HMB, Meine T, Werncke T, Olsson KM, Hoeper MM, Baumgart J, Wacker FK, Meyer BC, Renne J, Hinrichs JB.

Clin Radiol. 2019 Jun;74(6):437-444. doi: 10.1016/j.crad.2018.12.023. Epub 2019 Mar 16.

PMID:
30890260
30.

Extracorporeal membrane oxygenation and surgical embolectomy for high-risk pulmonary embolism.

Ius F, Hoeper MM, Fegbeutel C, Kühn C, Olsson K, Koigeldiyev N, Tudorache I, Warnecke G, Optenhöfel J, Puntigam JO, Schäfer A, Meyer BC, Hinrichs JB, Bauersachs J, Haverich A, Cebotari S.

Eur Respir J. 2019 Apr 25;53(4). pii: 1801773. doi: 10.1183/13993003.01773-2018. Print 2019 Apr. No abstract available.

PMID:
30728206
31.

Comprehensive three-dimensional morphology of neoangiogenesis in pulmonary veno-occlusive disease and pulmonary capillary hemangiomatosis.

Neubert L, Borchert P, Shin HO, Linz F, Wagner WL, Warnecke G, Laenger F, Haverich A, Stark H, Hoeper MM, Kuehnel M, Ackermann M, Jonigk D.

J Pathol Clin Res. 2019 Apr;5(2):108-114. doi: 10.1002/cjp2.125. Epub 2019 Feb 27.

32.

Development of hepatopulmonary syndrome during combination therapy for portopulmonary hypertension.

Olsson KM, Meyer K, Berliner D, Hoeper MM.

Eur Respir J. 2019 Jan 17;53(1). pii: 1801880. doi: 10.1183/13993003.01880-2018. Print 2019 Jan. No abstract available.

PMID:
30655448
33.

Selexipag treatment for pulmonary arterial hypertension associated with congenital heart disease after defect correction: insights from the randomised controlled GRIPHON study.

Beghetti M, Channick RN, Chin KM, Di Scala L, Gaine S, Ghofrani HA, Hoeper MM, Lang IM, McLaughlin VV, Preiss R, Rubin LJ, Simonneau G, Sitbon O, Tapson VF, Galiè N.

Eur J Heart Fail. 2019 Mar;21(3):352-359. doi: 10.1002/ejhf.1375. Epub 2019 Jan 11.

34.

Reduced Right Ventricular Output Reserve in Patients With Systemic Sclerosis and Mildly Elevated Pulmonary Artery Pressure.

Nagel C, Marra AM, Benjamin N, Blank N, Cittadini A, Coghlan G, Distler O, Denton CP, Egenlauf B, Fiehn C, Fischer C, Harutyunova S, Hoeper MM, Lorenz HM, Xanthouli P, Bossone E, Grünig E.

Arthritis Rheumatol. 2019 May;71(5):805-816. doi: 10.1002/art.40814. Epub 2019 Apr 10.

PMID:
30615302
35.

Right ventricular size and function under riociguat in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension (the RIVER study).

Marra AM, Halank M, Benjamin N, Bossone E, Cittadini A, Eichstaedt CA, Egenlauf B, Harutyunova S, Fischer C, Gall H, Ghofrani HA, Hoeper MM, Lange TJ, Olsson KM, Klose H, Grünig E.

Respir Res. 2018 Dec 19;19(1):258. doi: 10.1186/s12931-018-0957-y.

36.

Intensive care, right ventricular support and lung transplantation in patients with pulmonary hypertension.

Hoeper MM, Benza RL, Corris P, de Perrot M, Fadel E, Keogh AM, Kühn C, Savale L, Klepetko W.

Eur Respir J. 2019 Jan 24;53(1). pii: 1801906. doi: 10.1183/13993003.01906-2018. Print 2019 Jan.

37.

Initial combination therapy with ambrisentan + tadalafil on pulmonary arterial hypertension‒related hospitalization in the AMBITION trial.

Vachiéry JL, Galiè N, Barberá JA, Frost AE, Ghofrani HA, Hoeper MM, McLaughlin VV, Peacock AJ, Simonneau G, Blair C, Miller KL, Langley J, Rubin LJ; AMBITION Study Group.

J Heart Lung Transplant. 2019 Feb;38(2):194-202. doi: 10.1016/j.healun.2018.11.006. Epub 2018 Nov 22.

38.

Clinical course, treatment and outcome of Pneumocystis pneumonia in immunocompromised adults: a retrospective analysis over 17 years.

Schmidt JJ, Lueck C, Ziesing S, Stoll M, Haller H, Gottlieb J, Eder M, Welte T, Hoeper MM, Scherag A, David S.

Crit Care. 2018 Nov 19;22(1):307. doi: 10.1186/s13054-018-2221-8.

39.

Early therapeutic plasma exchange in septic shock: a prospective open-label nonrandomized pilot study focusing on safety, hemodynamics, vascular barrier function, and biologic markers.

Knaup H, Stahl K, Schmidt BMW, Idowu TO, Busch M, Wiesner O, Welte T, Haller H, Kielstein JT, Hoeper MM, David S.

Crit Care. 2018 Oct 30;22(1):285. doi: 10.1186/s13054-018-2220-9.

40.

Cologne consensus conference on pulmonary hypertension - Update 2018.

Rosenkranz S, Ghofrani HA, Grünig E, Klose H, Olschewski H, Hoeper MM.

Int J Cardiol. 2018 Dec 1;272S:1-3. doi: 10.1016/j.ijcard.2018.09.064. Epub 2018 Sep 22. No abstract available.

PMID:
30344062
41.

Risk assessment in patients with systemic sclerosis and pulmonary arterial hypertension.

Olsson KM, Hoeper MM.

Eur Respir J. 2018 Oct 18;52(4). pii: 1801745. doi: 10.1183/13993003.01745-2018. Print 2018 Oct. No abstract available.

PMID:
30337490
42.

Risk assessment in medically treated chronic thromboembolic pulmonary hypertension patients.

Delcroix M, Staehler G, Gall H, Grünig E, Held M, Halank M, Klose H, Vonk-Noordegraaf A, Rosenkranz S, Pepke-Zaba J, Opitz CF, Gibbs JSR, Lange TJ, Tsangaris I, Huscher D, Pittrow D, Olsson KM, Hoeper MM.

Eur Respir J. 2018 Nov 8;52(5). pii: 1800248. doi: 10.1183/13993003.00248-2018. Print 2018 Nov.

PMID:
30337446
43.

Cardio-pulmonary MRI for detection of treatment response after a single BPA treatment session in CTEPH patients.

Schoenfeld C, Hinrichs JB, Olsson KM, Kuettner MA, Renne J, Kaireit T, Czerner C, Wacker F, Hoeper MM, Meyer BC, Vogel-Claussen J.

Eur Radiol. 2019 Apr;29(4):1693-1702. doi: 10.1007/s00330-018-5696-4. Epub 2018 Oct 11.

PMID:
30311032
44.

Long-term safety and outcome of intravenous treprostinil via an implanted pump in pulmonary hypertension.

Richter MJ, Harutyunova S, Bollmann T, Classen S, Gall H, Gerhardt Md F, Grimminger F, Grimminger J, Grünig E, Guth S, Halank M, Heine A, Hoeper MM, Klose H, Lange TJ, Meyer K, Neurohr C, Nickolaus K, Olsson KM, Opitz CF, Rosenkranz S, Seyfarth HJ, Warnke C, Wiedenroth C, Ghofrani HA, Ewert R.

J Heart Lung Transplant. 2018 Oct;37(10):1235-1244. doi: 10.1016/j.healun.2018.06.006. Epub 2018 Jun 21.

PMID:
30293617
45.

Risk stratification strategy and assessment of disease progression in patients with pulmonary arterial hypertension: Updated Recommendations from the Cologne Consensus Conference 2018.

Leuchte HH, Ten Freyhaus H, Gall H, Halank M, Hoeper MM, Kaemmerer H, Kähler C, Riemekasten G, Ulrich S, Schwaiblmair M, Ewert R.

Int J Cardiol. 2018 Dec 1;272S:20-29. doi: 10.1016/j.ijcard.2018.08.084. Epub 2018 Sep 13. Review.

PMID:
30266353
46.

C-Arm computed tomography (CACT)-guided balloon pulmonary angioplasty (BPA): Evaluation of patient safety and peri- and post-procedural complications.

Maschke SK, Hinrichs JB, Renne J, Werncke T, Winther HMB, Ringe KI, Olsson KM, Hoeper MM, Wacker FK, Meyer BC.

Eur Radiol. 2019 Mar;29(3):1276-1284. doi: 10.1007/s00330-018-5694-6. Epub 2018 Sep 12.

PMID:
30209593
47.

Risk-stratified outcomes with initial combination therapy in pulmonary arterial hypertension: Application of the REVEAL risk score.

Frost AE, Hoeper MM, Barberá JA, Vachiery JL, Blair C, Langley J, Rubin LJ.

J Heart Lung Transplant. 2018 Dec;37(12):1410-1417. doi: 10.1016/j.healun.2018.07.001. Epub 2018 Sep 9.

PMID:
30209017
48.

Chronic thromboembolic pulmonary hypertension (CTEPH): Updated Recommendations from the Cologne Consensus Conference 2018.

Wilkens H, Konstantinides S, Lang IM, Bunck AC, Gerges M, Gerhardt F, Grgic A, Grohé C, Guth S, Held M, Hinrichs JB, Hoeper MM, Klepetko W, Kramm T, Krüger U, Lankeit M, Meyer BC, Olsson KM, Schäfers HJ, Schmidt M, Seyfarth HJ, Ulrich S, Wiedenroth CB, Mayer E.

Int J Cardiol. 2018 Dec 1;272S:69-78. doi: 10.1016/j.ijcard.2018.08.079. Epub 2018 Aug 28. Review.

PMID:
30195840
49.

Targeted therapy of pulmonary arterial hypertension: Updated recommendations from the Cologne Consensus Conference 2018.

Hoeper MM, Apitz C, Grünig E, Halank M, Ewert R, Kaemmerer H, Kabitz HJ, Kähler C, Klose H, Leuchte H, Ulrich S, Olsson KM, Distler O, Rosenkranz S, Ghofrani HA.

Int J Cardiol. 2018 Dec 1;272S:37-45. doi: 10.1016/j.ijcard.2018.08.082. Epub 2018 Aug 25.

PMID:
30190158
50.

Decompensated right heart failure, intensive care and perioperative management in patients with pulmonary hypertension: Updated recommendations from the Cologne Consensus Conference 2018.

Olsson KM, Halank M, Egenlauf B, Fistera D, Gall H, Kaehler C, Kortmann K, Kramm T, Lichtblau M, Marra AM, Nagel C, Sablotzki A, Seyfarth HJ, Schranz D, Ulrich S, Hoeper MM, Lange TJ.

Int J Cardiol. 2018 Dec 1;272S:46-52. doi: 10.1016/j.ijcard.2018.08.081. Epub 2018 Aug 26. Review.

PMID:
30190155

Supplemental Content

Loading ...
Support Center